Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Objectives: To study the effect of lymph node dissection (LND) at the time of nephrectomy and tumor thrombectomy on oncological outcomes in patients with renal cell carcinoma (RCC) and tumor thrombus. Patients and methods: The records of 1,978 patients with RCC and tumor thrombus who underwent radic...

Descripción completa

Detalles Bibliográficos
Autores: Tilki, D, Chandrasekar, T, Capitanio, U, Ciancio, G, Daneshmand, S, Gontero, P, Gonzalez, J, Haferkamp, A, Hohenfellner, M, Huang, WC, Espinos, EL, Lorentz, A, Martinez-Salamanca, JI, Master, VA, McKiernan, JM, Montorsi, F, Novara, G, Pahernik, S, Palou, J, Pruthi, RS, Rodriguez-Faba, O, Russo, P, Scherr, DS, Shariat, SF, Spahn, M, Terrone, C, Vera-Donoso, C, Zigeuner, R, Libertino, JA, Evans, CP
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2018
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p3957
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3957
https://escholarship.org/uc/item/8b00k123
Access Level:acceso abierto
Palabra clave:Renal cell carcinoma
Lymph node metastasis
Vena cava tumor thrombectomy
Lymphadenectomy
Survival
Inferior vena cava
id ES_6cc2eb97c4e2314831665c39aef8b4a1
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p3957
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Tilki, DChandrasekar, TCapitanio, UCiancio, GDaneshmand, SGontero, PGonzalez, JHaferkamp, AHohenfellner, MHuang, WCEspinos, ELLorentz, AMartinez-Salamanca, JIMaster, VAMcKiernan, JMMontorsi, FNovara, GPahernik, SPalou, JPruthi, RSRodriguez-Faba, ORusso, PScherr, DSShariat, SFSpahn, MTerrone, CVera-Donoso, CZigeuner, RLibertino, JAEvans, CPRenal cell carcinomaLymph node metastasisVena cava tumor thrombectomyLymphadenectomySurvivalInferior vena cavaObjectives: To study the effect of lymph node dissection (LND) at the time of nephrectomy and tumor thrombectomy on oncological outcomes in patients with renal cell carcinoma (RCC) and tumor thrombus. Patients and methods: The records of 1,978 patients with RCC and tumor thrombus who underwent radical nephrectomy and tumor thrombectomy from 1985 to 2014 at 24 centers were analyzed. None of the patients had distant metastases. Extent and pathologic results of LND were compared with respect to cancer-specific survival (CSS). Multivariable Cox regression models were used to quantify the effect of multiple covariates. Results: LND was performed in 1,026 patients. In multivariable analysis, the presence of LN metastasis, the number of positive LNs, and LN density were independently associated with cancer-specific mortality (CSM). Clinical node-negative (cN-) disease was documented in 573 patients, 447 of them underwent LND with 43 cN- patients (9.6%) revealing positive LNs at pathology. LN positive cN- patients showed significantly better CSS when compared to LN positive cN+ patients. In multivariable analysis, positive cN status in LN positive patients was a significant predictor of CSM (HR, 2.923; P = 0.015). Conclusions: The number of positive nodes harvested during LND and LN density was strong prognostic indicators of CSS, while number of removed LNs did not have a significant effect on CSS. The rate of pN1 patients among clinically node-negative patients was relatively high, and LND in these patients suggested a survival benefit. However, only a randomized trial can determine the absolute benefit of LND in this setting. Copyright (C) 2018 Elsevier Inc. All rights reserved.ELSEVIER SCIENCE INC2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3957https://escholarship.org/uc/item/8b00k123UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONSISSN: 10781439ISSNe: 18732496reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p39572026-06-14T12:41:47Z
dc.title.none.fl_str_mv Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
title Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
spellingShingle Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
Tilki, D
Renal cell carcinoma
Lymph node metastasis
Vena cava tumor thrombectomy
Lymphadenectomy
Survival
Inferior vena cava
title_short Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
title_full Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
title_fullStr Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
title_full_unstemmed Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
title_sort Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
dc.creator.none.fl_str_mv Tilki, D
Chandrasekar, T
Capitanio, U
Ciancio, G
Daneshmand, S
Gontero, P
Gonzalez, J
Haferkamp, A
Hohenfellner, M
Huang, WC
Espinos, EL
Lorentz, A
Martinez-Salamanca, JI
Master, VA
McKiernan, JM
Montorsi, F
Novara, G
Pahernik, S
Palou, J
Pruthi, RS
Rodriguez-Faba, O
Russo, P
Scherr, DS
Shariat, SF
Spahn, M
Terrone, C
Vera-Donoso, C
Zigeuner, R
Libertino, JA
Evans, CP
author Tilki, D
author_facet Tilki, D
Chandrasekar, T
Capitanio, U
Ciancio, G
Daneshmand, S
Gontero, P
Gonzalez, J
Haferkamp, A
Hohenfellner, M
Huang, WC
Espinos, EL
Lorentz, A
Martinez-Salamanca, JI
Master, VA
McKiernan, JM
Montorsi, F
Novara, G
Pahernik, S
Palou, J
Pruthi, RS
Rodriguez-Faba, O
Russo, P
Scherr, DS
Shariat, SF
Spahn, M
Terrone, C
Vera-Donoso, C
Zigeuner, R
Libertino, JA
Evans, CP
author_role author
author2 Chandrasekar, T
Capitanio, U
Ciancio, G
Daneshmand, S
Gontero, P
Gonzalez, J
Haferkamp, A
Hohenfellner, M
Huang, WC
Espinos, EL
Lorentz, A
Martinez-Salamanca, JI
Master, VA
McKiernan, JM
Montorsi, F
Novara, G
Pahernik, S
Palou, J
Pruthi, RS
Rodriguez-Faba, O
Russo, P
Scherr, DS
Shariat, SF
Spahn, M
Terrone, C
Vera-Donoso, C
Zigeuner, R
Libertino, JA
Evans, CP
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Renal cell carcinoma
Lymph node metastasis
Vena cava tumor thrombectomy
Lymphadenectomy
Survival
Inferior vena cava
topic Renal cell carcinoma
Lymph node metastasis
Vena cava tumor thrombectomy
Lymphadenectomy
Survival
Inferior vena cava
description Objectives: To study the effect of lymph node dissection (LND) at the time of nephrectomy and tumor thrombectomy on oncological outcomes in patients with renal cell carcinoma (RCC) and tumor thrombus. Patients and methods: The records of 1,978 patients with RCC and tumor thrombus who underwent radical nephrectomy and tumor thrombectomy from 1985 to 2014 at 24 centers were analyzed. None of the patients had distant metastases. Extent and pathologic results of LND were compared with respect to cancer-specific survival (CSS). Multivariable Cox regression models were used to quantify the effect of multiple covariates. Results: LND was performed in 1,026 patients. In multivariable analysis, the presence of LN metastasis, the number of positive LNs, and LN density were independently associated with cancer-specific mortality (CSM). Clinical node-negative (cN-) disease was documented in 573 patients, 447 of them underwent LND with 43 cN- patients (9.6%) revealing positive LNs at pathology. LN positive cN- patients showed significantly better CSS when compared to LN positive cN+ patients. In multivariable analysis, positive cN status in LN positive patients was a significant predictor of CSM (HR, 2.923; P = 0.015). Conclusions: The number of positive nodes harvested during LND and LN density was strong prognostic indicators of CSS, while number of removed LNs did not have a significant effect on CSS. The rate of pN1 patients among clinically node-negative patients was relatively high, and LND in these patients suggested a survival benefit. However, only a randomized trial can determine the absolute benefit of LND in this setting. Copyright (C) 2018 Elsevier Inc. All rights reserved.
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3957
https://escholarship.org/uc/item/8b00k123
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3957
https://escholarship.org/uc/item/8b00k123
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER SCIENCE INC
publisher.none.fl_str_mv ELSEVIER SCIENCE INC
dc.source.none.fl_str_mv UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
ISSN: 10781439
ISSNe: 18732496
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410291361513472
score 15,811543